• Q BioMed's Uttroside-B Receives Orphan Drug Designation for Liver Cancer americanpharmaceuticalreview
    February 03, 2021
    Q BioMed announced the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to Uttroside-B, a small molecule chemotherapeutic for the treatment of hepatocellular carcinoma (HCC), the most ...
PharmaSources Customer Service